HMGCS1 and non-small cell lung carcinoma: For example, multi-omics approaches combining ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS), scRNA-seq and spatial transcriptomics have identified prognostic biomarkers such as L-leucine and HMGCS1 for immunotherapy efficacy in NSCLC [89].